Financial Counselors Inc’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Financial Counselors Inc’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,600	Closed	–	–	533
2016 Q4	$0	Buy	+12,600	New	+$969	﹤0.01%	496
2016 Q2	$5K	Hold	12,600	–	–	﹤0.01%	439
2016 Q1	$5K	Hold	12,600	–	–	﹤0.01%	440
2015 Q4	$5K	Hold	12,600	–	–	﹤0.01%	444
2015 Q3	$7K	Hold	12,600	–	–	﹤0.01%	441
2015 Q2	$7K	Hold	12,600	–	–	﹤0.01%	448
2015 Q1	$10K	Hold	12,600	–	–	﹤0.01%	455
2014 Q4	$10K	Hold	12,600	–	–	﹤0.01%	446
2014 Q3	$13K	Buy	+12,600	New	+$12.2K	﹤0.01%	431

Other funds holding PVCT

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Financial Counselors Inc's PVCT Position: Q1 2017 in Review

Financial Counselors Inc sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q1 2017, closing a stake of 12,600 shares.

Financial Counselors Inc first reported a position in PVCT in Q3 2014 and held it in 9 quarters. The position peaked at $13K in Q3 2014. 3 funds tracked by Wall St. Rank hold PVCT as of Q1 2017.

Financial Counselors Inc reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q1 2017 after selling out during the quarter.
Financial Counselors Inc sold 12,600 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q1 2017.
Financial Counselors Inc first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q3 2014 and held it in 9 quarters.
Financial Counselors Inc's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $13K in Q3 2014.
3 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q1 2017.

Based on Financial Counselors Inc's 13F filing for Q1 2017, filed 12 May 2017.